Diagnostics and biomarkers

Blood test could identify patients who won’t respond to antidepressants

Researchers show that measuring inflammatory markers may help to identify patients less responsive to antidepressants.…

Taking low-dose aspirin during cancer treatment cuts deaths

Researchers say low-dose aspirin has a beneficial role as add-on to cancer treatment.…

Two peptides predict cardiomyopathy after brain haemorrhage

Swedish PhD student finds biomarkers that can identify subarachnoid haemorrhage patients at risk of cardiomyopathy.…

Liquid biopsy predicts treatment resistance in advanced prostate cancer

Patients with prostate cancer could be selected for alternative treatments using liquid biopsy, researchers say.…

Third of men with advanced prostate cancer could benefit from olaparib

A third of men with advanced prostate cancer could benefit from a drug currently licensed for women with ovarian cancer, according to the “remarkable” results of a study.…

Blood test could monitor tumour’s response to treatment

A blood test could match patients to experimental drugs that target their specific tumour mutations, accelerating the development of new cancer treatments, according to a first-of-a-kind study.…

Sequencing cancer genomes to tailor treatments to individual patients

Screening for hundreds of mutations in tumours is the most promising route to customised drug treatments for cancer.…

Biomarker test could help reduce unnecessary antibiotic prescribing

Point-of-care testing for a biomarker of bacterial infection would help to limit unnecessary antibiotic prescribing by GPs, suggests a systematic review.…